SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease

Recruiting N/A Interventional Study
Parkinson Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 – 75
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
80 (estimated)
Sponsor
Insel Gruppe AG, University Hospital Bern · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

With this study, the investigators want to investigate whether computerized speech analysis can be used to reliably and objectively detect motor, emotional, and cognitive fluctuations in Parkinson's disease patients.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Patients with Parkinson's Disease Inclusion Criteria: * Written informed consent * Idiopathic PD according to the Movement Disorders Society Criteria; * Age of participants \> 30 and ≤ 75 years; * Treatment with or without bilateral deep brain stimulation in the subthalamic nucleus; * Fluent in Ge…
Contacts

Paul Krack, Prof.

31 66 4 03 71

paul.krack@insel.ch

CONTACT

Mario Sousa, MD

31 664 23 49

mario.sousa@insel.ch

CONTACT